Epoch Biodesign, a London-based company developing enzymatic recycling technology, has closed a $12 million strategic funding round with participation from lululemon, KOMPAS VC, Happiness Capital, Extantia, Leitmotif and others. The new investment brings the company’s total funding to over $50 million.
Epoch is focused on advancing circularity in materials by enabling the recycling of nylon 6,6 without the need for virgin feedstock. Its process breaks down waste garments and other nylon-based materials into their original chemical components, such as adipic acid and HMDA, which can then be used to produce new, virgin-quality polymers and yarn.
The company’s technology is designed to process complex materials, including blended textiles, coated fibres and mixed plastics, helping to address waste streams that are typically difficult to recycle.
By working with existing yarn producers, Epoch aims to provide a drop-in solution that allows brands and manufacturers to improve supply chain sustainability without changing suppliers.
The funding will be used to expand Epoch’s global commercialisation efforts and deepen partnerships across industries, including apparel and automotive.
Would you like to write the first comment?
Login to post comments